Orazio Taglialatela-Scafati

Title: Orazio Taglialatela-Scafati: Innovator in Antitumour Research

Introduction

Orazio Taglialatela-Scafati is a notable inventor based in Acerra, Italy. He has made significant contributions to the field of biochemistry, particularly in the development of antitumour agents. His work focuses on novel adenyl dinucleotides that exhibit promising antitumour activity.

Latest Patents

Orazio holds a patent for "Adenyl dinucleotides with antitumour activity and a method of preparing thereof." This invention relates to novel adenyl dinucleotides, which are isomers of the dinucleotide Ap2A, characterized by specific formulae (I) and (II). The dinucleotides developed by Orazio demonstrate antitumour activity, especially against haematological tumours such as leukaemias and lymphomas. The patent also details an enzymatic method for preparing these dinucleotides and an enzymatic assay method for the dinucleotide of formula (I), which is based on its complete conversion to NAD. Orazio has 1 patent to his name.

Career Highlights

Throughout his career, Orazio has worked with esteemed institutions, including the University of Genoa and Advanced Biotechnology Center. His research has contributed to the understanding and potential treatment of various cancers.

Collaborations

Orazio has collaborated with notable colleagues such as Giovanna Basile and Umberto Benatti. Their combined expertise has furthered advancements in the field of biochemistry and cancer research.

Conclusion

Orazio Taglialatela-Scafati is a distinguished inventor whose work in antitumour research has the potential to impact cancer treatment significantly. His innovative approach to adenyl dinucleotides showcases the importance of continued research in the fight against cancer.